|
V12525
|
Sabcomeline HCl |
159912-58-0 |
Sabcomeline (BCI-224; BRL-55473; CEB-2424; SB-202026A) is a novel, potent and selective M1 receptor partial agonist that was under development for the treatment of Alzheimers disease. |
|
V50812
|
Y-08284 |
2688745-47-1 |
Y08284 is a potent, selective, orally bioactive CBP bromodomain inhibitor (antagonist) with IC50 of 4.21 nM. |
|
V19728
|
DHQZ-36 |
1542098-94-1 |
DHQZ-36 is a novel and potent small moleculeretrograde trafficking inhibitor which is able to block infection by several human and monkey polyomaviruses. |
|
V38994
|
Bifeprunox |
350992-10-8 |
Bifeprunox is a potent partial agonist of dopamine D2 and 5-HT1A receptors, with pKi of 7.19 and 8.83 for cortical 5-HT1A and striatal D2, respectively, and pEC50 of 6.37 for hippocampal 5-HT1A. |
|
V21296
|
Fotagliptin |
312954-58-7 |
Fotagliptin is a novel and potent dipeptidyl peptidase IV inhibitor |
|
V44690
|
DOPE-mPEG |
|
DOPE-mPEG, phospholipid polydisperse PEG (or DOPE liposome) |
|
V48037
|
BIBF 1202-13C,d3 |
|
BIBF 1202-13C,d3, 13C- and deuterium labeled BIBF 1202 |
|
V48529
|
Kukoamine A-d8 diHCl |
|
Kukoamine A-d8 diHCl, inhibitor of trypanothione reductase |
|
V46855
|
Antibacterial agent 86 |
|
anti-bacterial agent 86 (Compound A11) has the strongest activity and has anti-bacterial effect against methicillin-resistant Staphylococcus aureus. |